GC Lab Cell merger's cancellation risk has gone as the stock purchase cost was kept below the threshold. This post examines the stock swap arb spread situation and the KOSDA 150 index treatments.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.